Different doses of vonoprazan as the first-line treatment of Helicobacter pylori infection: A prospective cohort study
Objective To investigate the efficacy, safety, compliance, and economic benefits of low-dose or standard-dose vonoprazan quadruple therapy for the eradication of Helicobacter pylori (Hp). Methods A total of 531 patients who were diagnosed with Hp infection in our hospital from March to August 2023 w...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Precision Medicine
2024-08-01
|
| Series: | 精准医学杂志 |
| Subjects: | |
| Online Access: | https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1724744980794-2012328667.pdf |